Abstract

ObjectivesTo examine inter- and intra-observer agreement for four simple hepatobiliary phase (HBP)–based scores on gadoxetic acid (GA)–enhanced MRI and their correlation with liver function in patients with mixed chronic liver disease (CLD).MethodsThis single-center, retrospective study included 287 patients (62% male, 38% female, mean age 53.5 ± 13.7 years) with mixed CLD (20.9% hepatitis C, 19.2% alcoholic liver disease, 8% hepatitis B) who underwent GA-enhanced MRI of the liver for clinical care between 2010 and 2015. Relative liver enhancement (RLE), contrast uptake index (CUI), hepatic uptake index (HUI), and liver-to-spleen contrast index (LSI) were calculated by two radiologists independently using unenhanced and GA-enhanced HPB (obtained 20 min after GA administration) images; 50 patients selected at random were reviewed twice by one reader to assess intra-observer reliability. Agreement was assessed by intraclass correlation coefficient (ICC). The albumin-bilirubin (ALBI) score, the model of end-stage liver disease (MELD), and the Child-Turcotte-Pugh (CTP) score were calculated as standards of reference for hepatic function.ResultsIntra-observer ICCs ranged from 0.814 (0.668–0.896) for CUI to 0.969 (0.945–0.983) for RLE. Inter-observer ICCs ranged from 0.777 (0.605–0.874) for HUI to 0.979 (0.963–0.988) for RLE. All HBP-based scores correlated significantly (all p < 0.001) with the ALBI, MELD, and CTP scores and were able to discriminate patients with a MELD score ≥ 15 versus ≤ 14, with area under the curve values ranging from 0.760 for RLE to 0.782 for HUI.ConclusionGA-enhanced, MRI-derived, HBP-based parameters showed excellent inter- and intra-observer agreement. All HBP-based parameters correlated with clinical and laboratory scores of hepatic dysfunction, with no significant differences between each other.Key Points• Radiological parameters that quantify the hepatic uptake of gadoxetic acid are highly reproducible.• These parameters can be used interchangeably because they correlate with each other and with scores of hepatic dysfunction.• Assessment of these parameters may be helpful in monitoring disease progression.

Highlights

  • Chronic liver diseases (CLD) are a major worldwide health problem

  • There was no significant bias between observers for the calculation of Relative liver enhancement (RLE), liver-to-spleen contrast index (LSI), and contrast uptake index (CUI), whereas there was a small bias between observers for hepatic uptake index (HUI)

  • We show that the simple-to-obtain and simple-tocalculate magnetic resonance imaging (MRI)-derived HPB scores, i.e., the RLE, CUI, LSI, and HUI, have excellent intra- and inter-reader agreement

Read more

Summary

Introduction

Chronic liver diseases (CLD) are a major worldwide health problem. According to the Centers for Disease Control and Prevention, CLD were the 12th leading cause of death in the USA in 2015 [1]. The severity of liver disease and liver function is often based on clinical signs of disease and biochemical blood parameters, such as the levels of albumin and bilirubin, as well as prothrombin time Grading systems, such as the albuminbilirubin ratio (ALBI) score, the Child-Turcotte-Pugh (CTP), or the model of end-stage liver disease (MELD), combine these parameters to determine liver function and are used for treatment decision-making. In addition to these tests, the indocyanine clearance, 13C methacetin breath test, and galactose elimination capacity are established methods for the evaluation of liver function [13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call